Cancer Family
Malignant Head and Neck Neoplasm
CI-CAN-00000236Explore in graph →
1,432 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000236Explore in graph →
Clinical trials
5,449 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (629)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02004795 | BNCT and IG-IMRT for Recurrent Head and Neck Cancer | unknown | Phase 1 / Phase 2 | 28 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Dec 9, 2013 | clinicaltrials |
| NCT00003182 | Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck | unknown | Phase 1 / Phase 2 | 40 | Hope Cancer Institute, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00003251 | Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer | unknown | Phase 1 / Phase 2 | 46 | University of Illinois at ChicagoOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00003257 | Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer | unknown | Phase 2 | 39 | Aventis PharmaceuticalsINDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00004226 | Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy | unknown | Phase 1 / Phase 2 | — | University of Alabama at BirminghamOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00055770 | Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer | completed | Phase 1 / Phase 2 | 45 | National Cancer Institute (NCI)NIH | 1 | Nov 25, 2013 | clinicaltrials |
| NCT00095641 | S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer | withdrawn | Phase 2 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Nov 8, 2013 | clinicaltrials |
| NCT01172769 | Efficacy Study of Temsirolimus to Treat Head and Neck Cancer(TEMHEAD) | completed | Phase 2 | 42 | Hannover Medical SchoolOTHER | 1 | Nov 8, 2013 | clinicaltrials |
| NCT00004256 | Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer | completed | Phase 2 | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT01596868 | GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest China | completed | Phase 2 | 60 | Air Force Military Medical University, ChinaOTHER | 1 | Oct 30, 2013 | clinicaltrials |
| NCT00121628 | A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer | completed | Phase 2 | 184 | AmgenINDUSTRY | 0 | Oct 9, 2013 | clinicaltrials |
| NCT00085371 | Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas | completed | Phase 2 | 116 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00526149 | BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | completed | Phase 2 | 76 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Oct 7, 2013 | clinicaltrials |
| NCT00002951 | Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer | completed | Phase 2 | 53 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00015964 | ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck | completed | Phase 2 | 51 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT01075399 | Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors(HX4-200) | completed | Phase 2 | 50 | Siemens Molecular ImagingINDUSTRY | 0 | Aug 30, 2013 | clinicaltrials |
| NCT01271439 | Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal Carcinoma(REPLACE) | completed | Phase 2 | 60 | Sun Yat-sen UniversityOTHER | 1 | Aug 13, 2013 | clinicaltrials |
| NCT01118065 | Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer | unknown | Phase 2 | 42 | Leiden University Medical CenterOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01854203 | Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC(NPC) | unknown | Phase 2 / Phase 3 | 300 | Sun Yat-sen UniversityOTHER | 1 | Jul 30, 2013 | clinicaltrials |
| NCT01598402 | Efficacy of Prophylactic Treatment With Antibiotics During Concomitant Chemoradiotherapy in Patients With Head and Neck Cancer to Prevent Aspiration Pneumonia(PANTAP) | unknown | Phase 2 / Phase 3 | 106 | Radboud University Medical CenterOTHER | 1 | Jul 15, 2013 | clinicaltrials |
| NCT00101335 | Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia | completed | Phase 2 | — | Fox Chase Cancer CenterOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00002608 | Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors | completed | Phase 2 | 30 | Ottawa Regional Cancer CentreOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00004089 | Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00824343 | A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck Cancer(MONARCH) | completed | Phase 2 | 86 | Piramal Enterprises LimitedINDUSTRY | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00459043 | Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck | completed | Phase 2 | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00780312 | Physiotherapy Treatment for Patients Suffering From Head and Neck Cancer(HOHF) | completed | Phase 2 | 97 | Rigshospitalet, DenmarkOTHER | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00003580 | Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer | completed | Phase 2 | — | University of TennesseeOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00004901 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer | completed | Phase 1 / Phase 2 | — | Robert H. Lurie Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00002515 | Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00003443 | Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00005952 | Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors | completed | Phase 1 / Phase 2 | 30 | Duke UniversityOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019331 | Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00005814 | Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00020189 | Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00332865 | Swallow Exercise as Prophylaxis of Dysphagia After Radiotherapy | completed | Phase 1 / Phase 2 | 60 | University of AarhusOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00908024 | Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors | terminated | Phase 1 / Phase 2 | 54 | Bristol-Myers SquibbINDUSTRY | 2 | Jun 18, 2013 | clinicaltrials |
| NCT00091182 | Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment | completed | Phase 2 | 180 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00397787 | Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine | completed | Phase 2 | 64 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00062387 | Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | terminated | Phase 2 | 46 | National Cancer Institute (NCI)NIH | 1 | Jun 3, 2013 | clinicaltrials |
| NCT00006033 | Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer | completed | Phase 2 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT01830556 | Randomised Phase II, Cetuximab in Combination With 5FU and Cisplatin or Carboplatin Versus Cetuximab in Combination With Paclitaxel and Carboplatin for Treatment of Patients With Metastatic Squamous Cell Carcinoma of the Head and Neck(CETMET) | unknown | Phase 2 | 120 | Karolinska University HospitalOTHER | 2 | May 21, 2013 | clinicaltrials |
| NCT01736878 | Efficacy and Safety Study of Sorafenib to Treat Advanced Medullary Thyroid Carcinoma(SUMMIT) | withdrawn | Phase 2 | 0 | Eanm Research LtdNETWORK | 1 | May 17, 2013 | clinicaltrials |
| NCT00093665 | Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer | unknown | Phase 2 | 90 | Aichi Cancer CenterOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT01674374 | Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy | withdrawn | Phase 2 | 0 | Roswell Park Cancer InstituteOTHER | 0 | May 15, 2013 | clinicaltrials |
| NCT00410826 | Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer | completed | Phase 2 | 204 | University of WashingtonOTHER | 1 | May 10, 2013 | clinicaltrials |
| NCT00114790 | Boronophenylalanine (BPA)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment Head and Neck Tumors | completed | Phase 1 / Phase 2 | 30 | Boneca CorporationINDUSTRY | 1 | May 6, 2013 | clinicaltrials |
| NCT00056004 | Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia | completed | Phase 2 | 38 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 29, 2013 | clinicaltrials |
| NCT01192087 | Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy(ACCEPT) | unknown | Phase 1 / Phase 2 | 49 | Heidelberg UniversityOTHER | 1 | Apr 24, 2013 | clinicaltrials |
| NCT00003908 | S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | completed | Phase 2 | 68 | SWOG Cancer Research NetworkNETWORK | 1 | Apr 18, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Dec 9, 2013source: clinicaltrials